Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/LV

Cancer Science

Volumn 101, Issue 8, 2010, Pages 1853-1860

  Ito, Yuichi ^a,b   Nakanishi, Hayao ^a   Kodera, Yasuhiro ^b   Hirai, Takashi ^a   Nakao, Akimasa ^b   Kato, Tomoyuki ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE; 5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; BETA CATENIN; DIHYDROPYRIMIDINE DEHYDROGENASE; FOLINIC ACID; OROTATE PHOSPHORIBOSYLTRANSFERASE; THYMIDYLATE SYNTHASE; UFT; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER STAGING; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MALE; MICROMETASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; FLUOROURACIL; HUMANS; LEUCOVORIN; LYMPHATIC METASTASIS; MALE; MICE; MIDDLE AGED; OXONIC ACID; TEGAFUR; URACIL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77954876707     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01607.x     Document Type: Article

References (34)

1. Rosenberg R, Friederichs J, Schuster T. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3026 patients over a 25-year time period. Ann Surg 2008, 248:968-78.
2. André T, Boni C, Navarro M. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009, 27:3109-16.
3. Nakanishi H, Mochizuki Y, Kodera Y. Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Cancer Sci 2003, 94:112-8.
4. Ohashi N, Kodera Y, Nakanishi H. Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice. Int J Oncol 2005, 27:637-44.
5. Ninomiya I, Terada I, Yoshizumi T. Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum. Int J Cancer 2004, 112:135-42.
6. Fu XY, Besterman JM, Monosov A. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci U S A 1991, 88:9345-9.
7. Rashidi B, Sun FX, Jiang P. A nude mouse model of massive liver and lymph node metastasis of human colon cancer. Anticancer Res 2000, 20:715-22.
8. Flatmark K, Maelandsmo GM, Martinsen M. Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer 2004, 40:1593-8.
9. Fidler IJ. Orthotopic implantation of human colon carcinoma into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev 1991, 10:229-43.
10. Hoffman RM. Orthotopic metastasis mouse models for anti-cancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 1997, 17:343-59.
11. Kozaki K, Miyaishi O, Tsukamoto T. Establishment and characterization of a human lung cancer cell line NCI-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res 2000, 60:2535-40.
12. Fujii S, Ikenaka K, Fukushima M. Effects of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Jpn J Cancer Res 1978, 69:763-72.
13. Lembersky BC, Wieand HS, Petrelli NJ. Oral urcil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in Stage II and III carcinoma of the colon; results from the national surgical adjuvant breast and bowel project. J Clin Oncol 2006, 13:2059-64.
14. Fukushima M, Satake H, Uchida J. Preclinical antitumor efficacy of S-1: a new oral formulation of 5-fluorouracil on human tumor xenografts. Int J Oncol 1998, 13:693-8.
15. Shirasaka T, Nakano K, Takechi T. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Res 1996, 56:2602-6.
16. Nakanishi H, Hara H, Ikehara Y. Non-invasive and real-time monitoring of molecular targeting therapy for lymph node and peritoneal metastasis in nude mice bearing xenografts of human colorectal cancer cells tagged with GFP and DsRed. Proc SPIE 2007, 6449:644910-1.
17. Munesue S, Yoshitomi Y, Kusano Y. A novel function of syndecan-2, suppression of MMP-2 activation, which causes suppression of metastasis. J Biol Chem 2007, 282:28164-74.
18. Yokoyama H, Nakanishi H, Kodera Y. Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein (GFP)-tagged human gastric cancer cell line. Clin Cancer Res 2006, 12:361-8.
19. Price JE, Polyzos A, Zhang RD. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990, 50:717-21.
20. Nakanishi H, Ito S, Mochizuki Y. Evaluation of chemosensitivity of micrometastases with green fluorescent protein-tagged tumor models in mice. Chemosensitivity 2005, 111:351-62. Blumenthal RD, In, ed, Totowa, Humana Press
21. Arai T, Takubo K, Sawabe M. Pathologic characteristics of colorectal cancer in the elderly: a retrospective study of 947 surgical cases. J Clin Gastroenterol 2000, 31:67-72.
22. Kawabata Y, Tomita N, Monden T. Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum. Int J Cancer 1999, 84:33-8.
23. Hinoi T, Tani M, Lucas PC. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol 2001, 159:2239-48.
24. Royston D, Jackson DG. Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol 2009, 217:608-19.
25. Skobe M, Hawighorst T, Jackson DG. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001, 7:192-8.
26. Issa A, Le TX, Shoushtari AN. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res 2009, 69:349-57.
27. Vallböhmer D, Kuramochi H, Shimizu D. Molecular factors of 5-fluorouracil metabolism in colorectal cancer: analysis of primary tumor and lymph node metastasis. Int J Oncol 2006, 28:527-33.
28. Vallböhmer D, Yang DY, Kuramochi H. DPD is a molecular determinant of capecitabine efficacy in colorectal cancer. Int J Oncol 2007, 31:413-8.
29. Tatsumi K, Fukushima M, Shirasaka T. Inhibitiry effects of pyrimidine, barbituricacid and pyrimidine derivatives on 5-fluorouracil degradation in rat liver extracts. Jpn J Cancer Res 1987, 78:748-55.
30. Kuramochi H, Hayashi K, Uchida K. 5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis. Int J Cancer 2006, 119:522-6.
31. Takechi T, Nakano K, Uchida J. Antitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats. Cancer Chemother Pharmacol 1997, 39:205-11.
32. Ichikawa W, Takahashi T, Suto K. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer. Int J Cancer 2004, 112:967-73.
33. Mori K, Hasegawa M, Nishida M. Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. Int J Oncol 2000, 17:33-8.
34. Fukushima M, Morita M, Ikeda K. Population study of expression of thymidylate synthase and dehydropyrimidine dehydrogenase in patients with solid tumors. Int J Mol Med 2003, 12:893-844.